| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.58 | 0.01 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.56 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.54 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.49 | 0.02 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.44 | 0.07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.41 | 0.08 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.39 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.37 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.36 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.32 | 0.2 |